Ponesimod

FDA Drug Profile — PONVORY

Drug Details

Generic Name
Ponesimod
Brand Names
PONVORY
Application Number
NDA213498
Sponsor
Vanda Pharmaceuticals Inc.
NDC Codes
4
Dosage Forms
TABLET, FILM COATED, KIT
Routes
ORAL
Active Ingredients
PONESIMOD

Indications and Usage

1 INDICATIONS AND USAGE PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PONVORY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )